Improving Access to Superior Diagnostics For All
Who we are
We are a team dedicated to make a global impact in healthcare outcome for the most vulnerable.
What we do
Our team is committed to developing and deploying point-of-care diagnostic solution that are accessible, sensitive and accurate yet connected and cost-effective to improve the triage for high-burden infections and cancers.
Despite the development of centralized diagnostic testing laboratories around the world, access to testing for life-threatening diseases remain difficult for a large population, especially in countries with high-burden of infectious diseases. We aimed at implementing solutions that are complementary, bridging, and impactful at the local level.
Meet The Team
James Abbey, Ph.D.
Chief Executive Officer
Jim is an Instrumental academic leader in the UK and in the US. He co-founded the Center for NanoHealth as well as Calon Cardio Technologies Ltd. and Wildbytes Ltd., two medical device companies.
As the Director for Global & Corporate Partnerships at Texas A&M University System, he brought in $200 million yearly for research funding.
John McCrocklin
Chief Financial Officer
John spent over 10 years on the Board of Biomedical Research Group, a Phase 1-4 pharmaceutical testing company.
He has 52 years of experience in residential, commercial and industrial development and is a charter member of the Texas State University School of Business Advisory Council.
Sylvain Marcel, Ph.D.
Chief Operating Officer
Sylvain has over 20 years in biologics development, Research and Development, large-scale manufacturing, and regulatory support.
He established multiple laboratories and manufacturing facilities, with a focus on upstream and analytical activities.
Ron Musich
Chief Strategy Officer
Ron has an extensive background in Manufacturing, Sales, and Executive Management. He has held board seats, both public and private on multiple organizations, including medical device companies.
With his diversified background, Ron has an extended experience in corporate and business development.
Clint McCrocklin
Chief Technology Officer
Clint has over 16 years of professional experience as a healthcare data scientist in health policy analysis, data aggregation and assessment, cost-benefit studies and economic analysis, and military health systems data analysis.
Clint also has a strong educational background in Biostatistics, Health Informatics, Epidemiology, and Computer Science.
Scott Barrett
General Counsel, JD-MBA
Scott has over 20 years as a practicing attorney with a primary concentration of transactional law, mergers and acquisitions, corporate law, and corporate governance. Additionally, he has held the roles of acting General Counsel for numerous domestic entities and legal lead for the United States for several international corporations.
Scott has also served as Executive Director and Administrator of various health care entities tasked with leading the strategic, financial, and operations of the facilities.
Advisory Board
Mrs. Donna Boston
Advisory Consultant, DSBio Consulting
• Former Program Manager & Project Officer (HHS/ASPR/BARDA)
• Former Project Officer, HHS and BARDA developing and procuring Chem/Bio/Rad/Nuc medical countermeasures, diagnostic systems, and bio-dosimetry systems
• Former Program Manager for the JBAIDS program, an FDA-cleared bio-threat diagnostic system fielded to the Joint Services
Dr. Andrew Natsios
Executive Professor, International Affairs, Director of Scowcroft Institute of International Affairs at Texas A&M University and Executive Professor at the Bush School
• Former USAID Administrator (2001-2006)
• Former U.S. Special Envoy to Sudan (2006-2007)
• Former Program Advisory Committee Chair, HarvestPlus (International Agriculture Research)
Dr. Gerald Parker
Director of the Pandemic & Biosecurity Policy Program at the Scowcroft Institute at the Bush School, Associate Dean for Global One Health, College of Veterinary Medicine, Texas A&M University
• 36 years of public service in biodefense, emerging infectious diseases, global health security, & public health/medical preparedness
• Over 26 years of active duty, including roles as Commander & Deputy Commander at U.S. Army Medical Research Institute of Infectious Diseases
• Senior leader Homeland Security, HHS, & DOD, including Principal Deputy Assistant Secretary for Preparedness & Response (HHS)
Dr. Daniel Carson
Schlumberger Professor of Research & Advanced Studies, Rice University, Adjunct Professor of Gynecologic Oncology & Reproductive Sciences, University of Texas M.D. Anderson Cancer Center
• Former Dean, Natural Sciences, Former Vice Provost, Rice University
• Former Chair, Biological Sciences, University of Delaware
• Former University Distinguished Professor, University of Delaware (1998-2008)
Dr. Tim Claypole MBE
Professor Emeritus in the Faculty of Science and Engineering, Swansea University UK
• Founder and Director of the Welsh Centre for Printing and Coating, Swansea University
• Over 30 years expertise in rheology, color control, printing manufacturing systems, quality, and fluid mechanics
• Expert on ISO TC130 graphics arts and ISO TC119 printed electronics